Zeria Pharmaceutical Cash Flow Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	12,618	9,508	7,272	5,721	3,922
Depreciation & Amortization	7,554	7,555	6,148	5,399	4,435
Loss (Gain) From Sale of Assets	-	-	-	-	32
Loss (Gain) From Sale of Investments	208	-499	-19	-14	-375
Loss (Gain) on Equity Investments	276	-	-	-	-
Other Operating Activities	-1,039	-906	-530	-864	-512
Change in Accounts Receivable	-4,800	-2,075	-171	-2,029	825
Change in Inventory	-1,647	-863	-150	-542	-753
Change in Accounts Payable	567	1,052	-207	284	-40
Change in Other Net Operating Assets	-815	-1,589	814	995	-640
Operating Cash Flow	12,922	12,183	13,157	8,950	6,894
Operating Cash Flow Growth	6.07%	-7.40%	47.01%	29.82%	-4.92%
Capital Expenditures	-1,429	-2,900	-2,400	-1,064	-734
Cash Acquisitions	-	-623	-	-	-2,464
Sale (Purchase) of Intangibles	-1,304	-998	-257	-356	-15,398
Investment in Securities	1,662	473	58	-1,477	1,173
Other Investing Activities	21	96	25	5	-37
Investing Cash Flow	-1,050	-3,952	-2,574	-2,892	-17,460
Short-Term Debt Issued	-	-	279	-	12,744
Long-Term Debt Issued	3,273	500	500	16,158	4,500
Total Debt Issued	3,273	500	779	16,158	17,244
Short-Term Debt Repaid	-143	-560	-	-13,241	-
Long-Term Debt Repaid	-8,515	-5,778	-5,628	-3,388	-3,122
Total Debt Repaid	-8,658	-6,338	-5,628	-16,629	-3,122
Net Debt Issued (Repaid)	-5,385	-5,838	-4,849	-471	14,122
Repurchase of Common Stock	-	-	-673	-2,603	-1,154
Common Dividends Paid	-1,976	-1,935	-1,590	-1,538	-1,568
Other Financing Activities	-395	-351	-303	-229	-215
Financing Cash Flow	-7,756	-8,124	-7,415	-4,841	11,185
Foreign Exchange Rate Adjustments	749	2,402	1,346	564	169
Miscellaneous Cash Flow Adjustments	-2	1	-	128	-
Net Cash Flow	4,863	2,510	4,514	1,909	788
Free Cash Flow	11,493	9,283	10,757	7,886	6,160
Free Cash Flow Growth	23.81%	-13.70%	36.41%	28.02%	-7.07%
Free Cash Flow Margin	13.16%	12.26%	15.73%	13.25%	11.11%
Free Cash Flow Per Share	260.73	210.59	243.52	174.71	133.70
Cash Interest Paid	492	446	300	304	223
Cash Income Tax Paid	1,001	915	564	874	526
Levered Free Cash Flow	7,627	7,850	8,807	6,071	-12,962
Unlevered Free Cash Flow	7,910	8,136	9,017	6,268	-12,813
Change in Working Capital	-6,695	-3,475	286	-1,292	-608

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.